semaglutide and hashimoto The Thyroid Twist: How GLP-1 Agonists Are Influencing Autoimmune Thyroid Care hashimoto and semaglutide semaglutide and

Research indicates that patients who lose more than 5 percent of their body weight within the first three to four months are more likely to maintain that weight loss long-term

Before trying a GLP-1, he recommends a variety of diet options first

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is an FDA-approved dual GIP/GLP-1 receptor agonist that significantly slows gastric emptying

Compounded tirzepatide differs from FDA-approved Mounjaro and Zepbound in several important ways

You can either opt into the GLP-1 Rx plan or the branded plan, depending on what types of medications you want access to and what you can afford